What Factors Determine Treatment Outcome in Aneurysmal Subarachnoid Hemorrhage in the Modern Era? A Post Hoc STASH Analysis
Mario Teo(Southmead Hospital), Laura Montague, Andrew T. King(NHS Blood and Transplant), Christopher Smith(Pfizer (United States)), Mathew R. Guilfoyle(Cambridge University Hospitals NHS Foundation Trust), Martin Smith(Oxford University Hospitals NHS Trust), Gavin Spurling, Daniel Walsh, Marios C. Papadopoulos(St George’s University Hospitals NHS Foundation Trust), Keith W. Muir(University of Glasgow), Simon Bond(Cambridge University Hospitals NHS Foundation Trust), Martina Brown, Diederik Bulters(Addenbrooke's Hospital), Giles Critchley, Jane Gaylard, Peter J. Hutchinson(University of Cambridge), Gary A. Ford(University of Oxford), Elizabeth A. Warburton(University of Cambridge), Mohsen Javadpour, Sarah Hierons, Carole Turner(University of Cambridge), Pippa Tyrrell(University of Manchester), Corina Puppo(Universidad de la República), Ming Tseng, Bianca Tobin, R. J. Nelson, Paul Eldridge(University of Liverpool), Peter J. Kirkpatrick(Community Partners), Bejal Mistry, John Aeron‐Thomas, A. D. Mendelow(Newcastle University), Ros Taylor, Hugh K. Richards, Kelley Storey, Lorna Murray, Peter McCabe, Jeremy R. Pearson, Graham Teasdale, Gordon Murray(Nova Scotia Department of Agriculture)
Cited by 24
Related Papers
Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients
|The Lancet|2000|1.6k
Traumatic brain injury: progress and challenges in prevention, clinical care, and research
|The Lancet Neurology|2022|1.5k
MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset
|New England Journal of Medicine|2018|1.3k